Does LEDIPASVIR\SOFOSBUVIR Cause Tumour marker increased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Tumour marker increased have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.0% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.
5
Reports of Tumour marker increased with LEDIPASVIR\SOFOSBUVIR
0.0%
of all LEDIPASVIR\SOFOSBUVIR reports
1
Deaths
0
Hospitalizations
How Dangerous Is Tumour marker increased From LEDIPASVIR\SOFOSBUVIR?
Of the 5 reports, 1 (20.0%) resulted in death.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?
Fatigue (4,609)
Headache (4,203)
Nausea (1,471)
Drug ineffective (1,397)
Hepatitis c (1,076)
Diarrhoea (1,065)
Insomnia (1,021)
Hepatocellular carcinoma (640)
Vomiting (623)
Dizziness (604)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Tumour marker increased Risk?
LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE
LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT
LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR
LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE
LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB